ArticleOncotarget2018

Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.

Rebecca C Arend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.